Skip to main content
. 2022 Dec 23;72(6):1603ā€“1618. doi: 10.1007/s00262-022-03346-7

Table 1.

Clinico-pathological patient characteristics

Patient characteristics (nā€‰=ā€‰23)
Sex (m/f) 7/16
Age, years (mean) 62.8
TNM stage, n (%)*
pT1 5 (21.7)
pT2 3 (13)
pT3 12 (52.2)
pT4 1 (4.4)
pTx 2 (8.7)
p/cN0 10 (43.5)
p/cN1 4 (17.4)
p/cNx 9 (39.1)
p/cM0 8 (34.8)
p/cM1 9 (39.13)
p/cM2 1 (4.4)
p/cMx 5 (21.7)
Fuhrman Grade, n (%)
1 1 (4.4)
2 9 (39.1)
3 6 (26.1)
4 3 (13)
unknown 4 (17.4)
Histology, n (%)
Clear Cell 17 (73.9)
Papillary 4 (17.4)
Chromophobe 1 (4.4)
Collecting Duct 1 (4.4)
Tissue origin, n (%)
Primary tumor 15 (65.2)
Local recurrence 2 (8.7)
Metastatic lesion 6 (26.1)

*for all patients (including stage at the time of diagnosis for patients with advanced disease at the time of analysis)